Log in

NASDAQ:AKBAAkebia Therapeutics News Headlines

$11.59
+0.42 (+3.76 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$11.20
Now: $11.59
$11.74
50-Day Range
$11.17
MA: $12.23
$13.58
52-Week Range
$2.99
Now: $11.59
$13.71
Volume1.27 million shs
Average Volume927,509 shs
Market Capitalization$1.51 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.42

Headlines

Akebia Therapeutics (NASDAQ AKBA) News Headlines

Source:
DateHeadline
Akebia Therapeutics (NASDAQ:AKBA) Downgraded by Zacks Investment Research to "Hold"Akebia Therapeutics (NASDAQ:AKBA) Downgraded by Zacks Investment Research to "Hold"
marketbeat.com - July 15 at 4:54 PM
Akebia Therapeutics Announces Data on Different Dosing Regimens of Ferric Citrate for Iron Deficiency Anemia Presented at 57thAkebia Therapeutics Announces Data on Different Dosing Regimens of Ferric Citrate for Iron Deficiency Anemia Presented at 57th
www.bloomberg.com - August 3 at 9:36 AM
Akebia Therapeutics to Report Second Quarter 2020 Financial ResultsAkebia Therapeutics to Report Second Quarter 2020 Financial Results
finance.yahoo.com - August 3 at 9:36 AM
Akebia Therapeutics (NASDAQ:AKBA) Stock Price Down 6.2%Akebia Therapeutics (NASDAQ:AKBA) Stock Price Down 6.2%
www.americanbankingnews.com - July 31 at 8:18 PM
Morgan Stanley Boosts Akebia Therapeutics (NASDAQ:AKBA) Price Target to $12.00Morgan Stanley Boosts Akebia Therapeutics (NASDAQ:AKBA) Price Target to $12.00
www.americanbankingnews.com - July 16 at 6:05 AM
Akebia Therapeutics (NASDAQ:AKBA) Receives "Buy" Rating from HC WainwrightAkebia Therapeutics (NASDAQ:AKBA) Receives "Buy" Rating from HC Wainwright
www.americanbankingnews.com - July 16 at 4:33 AM
Akebia launches vadadustat study in COVID-19 complicationAkebia launches vadadustat study in COVID-19 complication
seekingalpha.com - July 14 at 12:13 PM
Akebia Announces Initiation of Investigator-Sponsored Study Evaluating Vadadustat for Prevention and Treatment of ARDS in Patients Hospitalized with COVID-19Akebia Announces Initiation of Investigator-Sponsored Study Evaluating Vadadustat for Prevention and Treatment of ARDS in Patients Hospitalized with COVID-19
finance.yahoo.com - July 14 at 12:13 PM
Akebia Initiates Vadadustat Study In Covid-19 PatientsAkebia Initiates Vadadustat Study In Covid-19 Patients
finance.yahoo.com - July 14 at 12:13 PM
Akebia Therapeutics Inc (NASDAQ:AKBA) Given Average Recommendation of "Buy" by BrokeragesAkebia Therapeutics Inc (NASDAQ:AKBA) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 14 at 6:30 AM
What Is The Ownership Structure Like For Akebia Therapeutics, Inc. (NASDAQ:AKBA)?What Is The Ownership Structure Like For Akebia Therapeutics, Inc. (NASDAQ:AKBA)?
finance.yahoo.com - July 6 at 1:23 PM
Akebias Vadadustat OKd in Japan for CKD anemiaAkebia's Vadadustat OK'd in Japan for CKD anemia
seekingalpha.com - June 29 at 12:10 PM
Akebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult PatientsAkebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult Patients
finance.yahoo.com - June 29 at 12:10 PM
Hedge Funds Are Buying Akebia Therapeutics Inc (AKBA)Hedge Funds Are Buying Akebia Therapeutics Inc (AKBA)
finance.yahoo.com - June 23 at 3:41 PM
Akebia Therapeutics Launches AkebiaShares, a Peer-to-Peer Educational Program Series for the Renal CommunityAkebia Therapeutics Launches AkebiaShares, a Peer-to-Peer Educational Program Series for the Renal Community
finance.yahoo.com - June 22 at 1:21 PM
Akebia names finance chiefAkebia names finance chief
seekingalpha.com - June 18 at 6:45 PM
Akebia Therapeutics Announces New Chief Financial OfficerAkebia Therapeutics Announces New Chief Financial Officer
finance.yahoo.com - June 18 at 6:45 PM
Akebia Therapeutics Inc.Akebia Therapeutics Inc.
www.barrons.com - June 17 at 2:30 PM
Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - June 16 at 1:49 PM
Akebia Therapeutics Announces Data on Different Dosing Regimens of Ferric Citrate for Iron Deficiency Anemia Presented at 57th ERA-EDTA Virtual CongressAkebia Therapeutics Announces Data on Different Dosing Regimens of Ferric Citrate for Iron Deficiency Anemia Presented at 57th ERA-EDTA Virtual Congress
finance.yahoo.com - June 10 at 8:50 AM
Akebia Therapeutics: A Clear Path To A Blockbuster CKD-Anemia TreatmentAkebia Therapeutics: A Clear Path To A Blockbuster CKD-Anemia Treatment
seekingalpha.com - May 31 at 11:44 PM
Akebia Therapeutics to Present at Jefferies Virtual Global Healthcare ConferenceAkebia Therapeutics to Present at Jefferies Virtual Global Healthcare Conference
finance.yahoo.com - May 26 at 8:53 AM
Akebia Therapeutics Announces Change to Virtual Annual Meeting of StockholdersAkebia Therapeutics Announces Change to Virtual Annual Meeting of Stockholders
finance.yahoo.com - May 21 at 6:52 PM
Akebia Therapeutics Announces Full Exercise of Underwriters Option to Purchase Additional SharesAkebia Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - May 19 at 8:55 PM
Akebia Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional SharesAkebia Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - May 19 at 8:55 PM
Akebia announces filing in Japan expanded use of Riona tabletsAkebia announces filing in Japan expanded use of Riona tablets
seekingalpha.com - May 18 at 6:37 PM
Akebia announces filing in Japan for expanded use of RionaAkebia announces filing in Japan for expanded use of Riona
seekingalpha.com - May 18 at 1:37 PM
Akebia Therapeutics Announces Collaboration Partner's Submission of Supplemental New Drug Application for Use of Riona® (ferric citrate hydrate) to Treat Adult Patients with Iron Deficiency Anemia in JapanAkebia Therapeutics Announces Collaboration Partner's Submission of Supplemental New Drug Application for Use of Riona® (ferric citrate hydrate) to Treat Adult Patients with Iron Deficiency Anemia in Japan
finance.yahoo.com - May 18 at 8:37 AM
Akebia Therapeutics, Inc. (AKBA) Shares March Higher, Can It Continue?Akebia Therapeutics, Inc. (AKBA) Shares March Higher, Can It Continue?
finance.yahoo.com - May 13 at 1:59 PM
Akebia Therapeutics prices upsized equity offering, Shares down 5% after hoursAkebia Therapeutics prices upsized equity offering, Shares down 5% after hours
seekingalpha.com - May 12 at 2:24 AM
Akebia Therapeutics Announces Pricing of Upsized Public Offering of Common StockAkebia Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
finance.yahoo.com - May 11 at 9:24 PM
How Akebia Therapeutics (AKBA) Stock Stands Out in a Strong IndustryHow Akebia Therapeutics (AKBA) Stock Stands Out in a Strong Industry
finance.yahoo.com - May 11 at 4:19 PM
Akebia Therapeutics Announces Proposed Public Offering of Common StockAkebia Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - May 11 at 4:19 PM
Edited Transcript of AKBA earnings conference call or presentation 5-May-20 12:30pm GMTEdited Transcript of AKBA earnings conference call or presentation 5-May-20 12:30pm GMT
finance.yahoo.com - May 8 at 10:37 PM
Akebia Therapeutics to Present at RBC Capital Markets Global Healthcare Virtual ConferenceAkebia Therapeutics to Present at RBC Capital Markets Global Healthcare Virtual Conference
finance.yahoo.com - May 8 at 5:37 PM
US$17.13 - Thats What Analysts Think Akebia Therapeutics, Inc. (NASDAQ:AKBA) Is Worth After These ResultsUS$17.13 - That's What Analysts Think Akebia Therapeutics, Inc. (NASDAQ:AKBA) Is Worth After These Results
finance.yahoo.com - May 7 at 5:55 PM
US$17.13 - That's What Analysts Think Akebia Therapeutics, Inc. (NASDAQ:AKBA) Is Worth After These ResultsUS$17.13 - That's What Analysts Think Akebia Therapeutics, Inc. (NASDAQ:AKBA) Is Worth After These Results
finance.yahoo.com - May 7 at 5:55 PM
Akebia Spikes 38% On Pivotal Trial Readout; And Further Upside Lies AheadAkebia Spikes 38% On Pivotal Trial Readout; And Further Upside Lies Ahead
finance.yahoo.com - May 6 at 4:59 AM
Stock Alert: Akebia Therapeutics Up 25% As Drug Trial Achieves Positive ResultsStock Alert: Akebia Therapeutics Up 25% As Drug Trial Achieves Positive Results
www.nasdaq.com - May 5 at 5:28 PM
Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue EstimatesAkebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates
www.nasdaq.com - May 5 at 5:28 PM
Akebias shares jump on late-stage clinical trial results for kidney disease drugAkebia's shares jump on late-stage clinical trial results for kidney disease drug
www.msn.com - May 5 at 8:49 AM
Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis ...Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis ...
www.businesswire.com - May 5 at 8:49 AM
Akebia Therapeutics, Inc. 2020 Q1 - Results - Earnings Call PresentationAkebia Therapeutics, Inc. 2020 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 5 at 8:49 AM
Akebia up 25% premarket on positive vadadustat dataAkebia up 25% premarket on positive vadadustat data
seekingalpha.com - May 5 at 8:49 AM
Akebia's shares jump on late-stage clinical trial results for kidney disease drugAkebia's shares jump on late-stage clinical trial results for kidney disease drug
finance.yahoo.com - May 5 at 8:49 AM
Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Financial ResultsAkebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 5 at 8:49 AM
Akebia Therapeutics to Report First Quarter 2020 Financial Results and Discuss Recent Business HighlightsAkebia Therapeutics to Report First Quarter 2020 Financial Results and Discuss Recent Business Highlights
finance.yahoo.com - April 28 at 9:13 AM
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Akebia Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims.INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Akebia Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims.
finance.yahoo.com - April 10 at 11:00 PM
Akebia Therapeutics Appoints Myles Wolf, M.D., M.M.Sc., Chief of Nephrology and Professor at Duke University School of Medicine, to Board of DirectorsAkebia Therapeutics Appoints Myles Wolf, M.D., M.M.Sc., Chief of Nephrology and Professor at Duke University School of Medicine, to Board of Directors
finance.yahoo.com - April 7 at 5:37 PM
Edited Transcript of AKBA earnings conference call or presentation 10-Mar-20 1:00pm GMTEdited Transcript of AKBA earnings conference call or presentation 10-Mar-20 1:00pm GMT
finance.yahoo.com - March 26 at 11:43 PM
Akebia Therapeutics to Present Research at NKF 2020 Spring Clinical Meetings Live Virtual ConferenceAkebia Therapeutics to Present Research at NKF 2020 Spring Clinical Meetings Live Virtual Conference
finance.yahoo.com - March 23 at 12:23 PM
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.